Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
James A. Mcnulty currently holds 120,968 shares of Inhibitor Therapeutics, Inc. (INTI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James A. Mcnulty has been a net seller of INTI stock. They have purchased $37.7K and sold $1.9M worth of shares.
James A. Mcnulty's most recent insider trade was on Nov 4, 2024, when they sold 120,968 shares at $0.00 per share.
James A. Mcnulty serves as Executive at Inhibitor Therapeutics, Inc. (INTI). They have executed 44 insider transactions totaling $1.9M over their tenure at the company.
James A. Mcnulty holds the position of Executive at Inhibitor Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
James A. Mcnulty has shown a selling trading pattern, with $37.7K in total purchases and $1.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by James A. Mcnulty was on Jan 24, 2014, when they sold $778.9K worth of BDSI shares. This transaction involved 89,223 shares at $8.73 per share.
James A. Mcnulty currently owns 120,968 shares of Inhibitor Therapeutics, Inc. (INTI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of James A. Mcnulty's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. James A. Mcnulty has 44 Form 4 filings on record as an insider at Inhibitor Therapeutics, Inc..
Set alerts for James A. Mcnulty and 40,000+ other insiders.